Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Axel Ullrich0
Johannes Bange0
Date of Patent
May 12, 2009
Patent Application Number
10503242
Date Filed
January 30, 2003
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to the use of Fibroblast-Growth Factor Receptor (FGFR) agonists for the diagnosis, prevention and/or treatment of pathological conditions including, but not limited to hyperproliferative disorders, bone diseases and vascular diseases. Particularly, the use of FGFR-4 agonists, e.g. anti-FGFR-4 antibodies is described. Further, the invention relates to a pharmaceutical composition comprising the agonist as described above and a screening procedure.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
